World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
46325
World Ranking
9119
National Ranking
889

Immunology

D-Index
97
Citations
46250
World Ranking
805
National Ranking
72

Andrew L. Mellor publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Andrew L. Mellor sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 270 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Andrew L. Mellor D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew L. Mellor sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 97 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Andrew L. Mellor is affiliated with Newcastle University in the United Kingdom. Their research primarily focuses on medicine, with significant contributions to immunology and microbiology. They have published extensively across several subfields, including immunology, oncology, molecular biology, materials chemistry, and rheumatology.

Their work covers a range of main topics that include:

  • Immune Cell Function and Interaction
  • Tryptophan and brain disorders
  • Interferon and immune responses
  • Peptidase Inhibition and Analysis
  • Cancer Immunotherapy and Biomarkers
  • Hydrogels: synthesis, properties, applications
  • T-cell and B-cell Immunology

Mellor has contributed to several scientific papers, with notable recent publications including:

  • CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint, 2020, Nature Communications
  • Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment, 2020, Cell Death and Differentiation
  • Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation, 2020, American Journal of Transplantation
  • Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity, 2020, Journal for ImmunoTherapy of Cancer
  • Genipin-crosslinked chitosan hydrogels: Preliminary evaluation of the in vitro biocompatibility and biodegradation, 2021, Journal of Applied Polymer Science

Frequent co-authors in Mellor's work include Lei Huang, Henrique Lemos, Arthur G. Pratt, John D. Isaacs, and Amy E. Anderson.

Several publication venues have featured their work multiple times, which include:

  • Journal of Applied Polymer Science
  • Frontiers in Immunology
  • Annals of the Rheumatic Diseases
  • Nature Communications
  • Cell Death and Differentiation

Mellor has also contributed to book publications, notably with Yale University Press, with the work titled The Northern Silence published in 2022.

Best Publications

  • Prevention of allogeneic fetal rejection by tryptophan catabolism

    David H. Munn;Min Zhou;John T. Attwood;Igor Bondarev

  • IDO expression by dendritic cells: tolerance and tryptophan catabolism.

    Andrew L. Mellor;David H. Munn

  • Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

    Brian J. Miller;Peter Buckley;Wesley Seabolt;Andrew Mellor

  • INHIBITION OF T CELL PROLIFERATION BY MACROPHAGE TRYPTOPHAN CATABOLISM

    David H. Munn;Ebrahim Shafizadeh;John T. Attwood;Igor Bondarev

  • GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

    David H. Munn;Madhav D. Sharma;Babak Baban;Heather P. Harding

  • Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase

    David H. Munn;Madhav D. Sharma;Jeffrey R. Lee;Kanchan G. Jhaver

  • Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

    David H. Munn;Andrew L. Mellor

  • Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

    David H. Munn;Madhav D. Sharma;Deyan Hou;Babak Baban

  • Indoleamine 2,3 dioxygenase and metabolic control of immune responses

    David H. Munn;Andrew L. Mellor

  • IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance

    David H. Munn;Andrew L. Mellor

  • Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

    Madhav D. Sharma;Babak Baban;Phillip Chandler;De Yan Hou

  • cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines

    Christer Betsholtz;Ann Johnsson;Carl-Henrik Heldin;Bengt Westermark

  • Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

    Andrew L Mellor;David H Munn

  • Eosinophilia in transgenic mice expressing interleukin 5.

    Lindsay A. Dent;Malcolm Strath;Andrew L. Mellor;Colin J. Sanderson

  • Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses

    De Yan Hou;Alexander J. Muller;Madhav D. Sharma;James DuHadaway

  • Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells

    David H. Munn;Madhav D. Sharma;Andrew L. Mellor

  • Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion

    Andrew L. Mellor;Babak Baban;Phillip Chandler;Brendan Marshall

  • IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells

    Babak Baban;Phillip R. Chandler;Madhav D. Sharma;Jeanene Pihkala

  • Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

    Andrew L. Mellor;Jayabalan Sivakumar;Phillip Chandler;Kimberly Smith

  • A critical role for the programmed death ligand 1 in fetomaternal tolerance.

    Indira Guleria;Arezou Khosroshahi;Mohammed Javeed I Ansari;Antje Habicht

  • Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division

    Geon Kook Lee;Hyeon Jin Park;Megan Macleod;Phillip Chandler

Frequent Co-Authors

David H. Munn
David H. Munn Augusta University
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
George C. Prendergast
George C. Prendergast Lankenau Institute for Medical Research
Pandelakis A. Koni
Pandelakis A. Koni Elixiron Immunotherapeutics (Taiwan)
Alexander J. Muller
Alexander J. Muller Lankenau Institute for Medical Research
Kebin Liu
Kebin Liu Augusta University
Peter F. Buckley
Peter F. Buckley University of Tennessee Health Science Center
Richard A. Flavell
Richard A. Flavell Yale University
Hideo Yagita
Hideo Yagita Juntendo University
Elizabeth M. Simpson
Elizabeth M. Simpson University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare disciplines, including nursing and advanced practice roles. For those interested in expanding their clinical expertise, exploring acnp programs can be a valuable step. These programs prepare nurse practitioners for acute care settings, which are critical for managing immunology-related conditions.

For individuals looking to fast-track their nursing careers, accelerated nurse practitioner programs offer an efficient pathway to becoming a nurse practitioner. Additionally, those without a nursing background can consider online bsn programs for non nurses, which provide flexible options to enter the nursing field and build foundational healthcare knowledge relevant to immunology research or practice.

For a less competitive entry point into nursing, exploring the easiest absn to get into programs can help prospective students start their healthcare education journey efficiently. These programs can pave the way for further specialization in immunology or related healthcare careers.

Best Scientists Citing Andrew L. Mellor

Trending Scientists

Recently Published Articles